Olema drops after hours on AstraZeneca Etcamah data

Press Room

2 hours ago

MF3d

Abstract digital chart with arrow sign, stock market crash and trading collapse, financial crisis and economic downturn. Closing positions on exchanges. Margin call. Business concept — MF3d

Olema Pharmaceuticals (OLMA), which is developing the estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) palazestrant, is down ~15% in after-hours trading Friday after AstraZeneca (AZN) disclosed the failure of its own SERD and

Exit mobile version